NICE recommendation expands patient eligibility for AbbVie’s Ozurdex

12th August 2022 Uncategorised 0

Treatment becomes an option for treating visual impairment caused by diabetic macular oedema, regardless of lens status

More: NICE recommendation expands patient eligibility for AbbVie’s Ozurdex
Source: News